Acorda Therapeutics (ACOR) Stock Moves -0.11%: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Acorda Therapeutics (ACOR) closed at $0.93 in the latest trading session, marking a -0.11% move from the prior day. This move was narrower than the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Prior to today’s trading, shares of the drugmaker had lost 10.58% over the past month. This has lagged the Medical sector’s loss of 8.16% and the S&P 500’s loss of 10.5% in that time.

ACOR will be looking to display strength as it nears its next earnings release. In that report, analysts expect ACOR to post earnings of -$0.35 per share. This would mark year-over-year growth of 37.5%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $39.34 million, down 10.87% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$1.03 per share and revenue of $137.11 million, which would represent changes of +40.12% and -28.74%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for ACOR. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

What is Horseracing?

Last year was the Super Bowl for the third time and the seventh year of the game itself. With the regular season over and...

Business Cards – Business Cards For Beginners

If you've ever run into a hard-to-sell piece of business on a club or social occasion, you've most likely noticed how much difference a...

The Papers: England v Scotland build-up and arena bomb reporton June 17, 2021 at 10:37 pm

A mix of stories lead Friday's newspaper front pages - including a look ahead to Friday's Euros match.A mix of stories lead Friday's newspaper...

Covid-19: Hope for treatable virus, final vaccine push, and lockdown museumson February 13, 2021 at 8:23 am

Five things you need to know about the coronavirus pandemic this Saturday morning.There have been a few football managers who have had to take...

Thomas Tuchel: Chelsea manager signs contract extension until 2024on June 4, 2021 at 12:32 pm

Chelsea manager Thomas Tuchel signs a contract extension until the summer of 2024.Tuchel, 47, signed an initial 18-month deal when he replaced Frank Lampard...
Home of Science
Follow me